Renal Cancer - Results from #2700

Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: A population-based study. July 7, 2020

Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors. July 7, 2020

Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer. July 7, 2020

Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer. July 7, 2020

An evaluation of the role of tumor load in cytoreductive nephrectomy. July 7, 2020

The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort. July 6, 2020

DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy. July 6, 2020

Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers. July 3, 2020

Resveratrol Inhibition of Renal Cancer Stem Cell Characteristics and Modulation of the Sonic Hedgehog Pathway. July 3, 2020

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. July 3, 2020

TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma. July 2, 2020

Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma. July 1, 2020

To Be or "Node" to Be: Nodal Disease and the Role of Lymphadenectomy in the Treatment of Renal Cell Carcinoma. July 1, 2020

Trigonometric Concept of Fluoroscopy-Guided Percutaneous Renal Access June 30, 2020

Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. June 30, 2020

Real-world Experience With Sunitinib Treatment in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to Risk Score. June 30, 2020

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events. June 29, 2020

Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer. June 29, 2020

Results of surgical treatment of inferior vena cava tumor thrombi in renal cell carcinoma. June 26, 2020

Solitary, Late Metastatic Recurrence of Renal Cell Carcinoma to the Pancreas: A Case Report. June 26, 2020

Page 136 of 457